Literature DB >> 2426118

Substance P and human nasal mucociliary activity.

G Karlsson, U Pipkorn, L Andreasson.   

Abstract

Substance P (SP), a potent inflammatory agent, has been found in sensory nerve fibres in the nasal mucosa in several experimental animals as well as in man. It may participate in the inflammatory response as part of the mucosal defence against foreign materials. In experimental animals SP has been found to increase mucociliary in airway mucosa. The present study was performed in order to find out the relationship between topically applied SP and nasal mucociliary function in humans. Thirteen healthy volunteers were challenged with 65 micrograms SP or placebo in a randomized cross over fashion and mucociliary transport time was determined each time using the saccharine dye test. The dose of SP was chosen after an open dose-response study. No statistically significant change in the mucociliary transport time was found after challenge with SP as compared to placebo. The possible reasons for this are discussed.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2426118     DOI: 10.1007/bf00541544

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  8 in total

1.  Effects of neuropeptides on mucociliary activity.

Authors:  S Lindberg; J C Hybbinette; U Mercke
Journal:  Ann Otol Rhinol Laryngol       Date:  1986 Jan-Feb       Impact factor: 1.547

2.  A comparison of nasal and tracheobronchial clearance.

Authors:  I Andersen; P Camner; P L Jensen; K Philipson; D F Proctor
Journal:  Arch Environ Health       Date:  1974-11

3.  Protective reflexes and vascular effects in the nasal mucosa elicited by activation of capsaicin-sensitive substance P-immunoreactive trigeminal neurons.

Authors:  L Lundblad
Journal:  Acta Physiol Scand Suppl       Date:  1984

4.  Effects of chemical mediators of anaphylaxis on ciliary function.

Authors:  A Wanner; D Maurer; W M Abraham; Z Szepfalusi; M Sielczak
Journal:  J Allergy Clin Immunol       Date:  1983-12       Impact factor: 10.793

5.  Aerosol distribution in the nose.

Authors:  N Mygind; S Vesterhauge
Journal:  Rhinology       Date:  1978-06       Impact factor: 3.681

6.  Substance-P-containing nerve fibers in the nasal mucosa.

Authors:  R Uddman; L Malm; F Sundler
Journal:  Arch Otorhinolaryngol       Date:  1983

7.  The nasal mucosa in immunodeficiency. Surface morphology, mucociliary function and bacteriological findings in adult patients with common variable immunodeficiency or selective IgA deficiency.

Authors:  G Karlsson; H A Hansson; B Petruson; J Björkander
Journal:  Acta Otolaryngol       Date:  1985 Nov-Dec       Impact factor: 1.494

8.  A substance P antagonist inhibits vagally induced increase in vascular permeability and bronchial smooth muscle contraction in the guinea pig.

Authors:  J M Lundberg; A Saria; E Brodin; S Rosell; K Folkers
Journal:  Proc Natl Acad Sci U S A       Date:  1983-02       Impact factor: 11.205

  8 in total
  4 in total

1.  Reversibility and reproducibility of histamine induced plasma leakage in nasal airways.

Authors:  C Svensson; C R Baumgarten; U Pipkorn; U Alkner; C G Persson
Journal:  Thorax       Date:  1989-01       Impact factor: 9.139

Review 2.  Nasal provocation.

Authors:  U Pipkorn
Journal:  Clin Rev Allergy       Date:  1988

3.  Effects of nicotine on the human nasal mucosa.

Authors:  L Greiff; P Wollmer; I Erjefält; M Andersson; U Pipkorn; C G Persson
Journal:  Thorax       Date:  1993-06       Impact factor: 9.139

4.  Distinctive patterns of release of neuroendocrine peptides after nasal challenge of allergic subjects with ryegrass antigen.

Authors:  K B Walker; M H Serwonska; F H Valone; W S Harkonen; O L Frick; K H Scriven; W D Ratnoff; J G Browning; D G Payan; E J Goetzl
Journal:  J Clin Immunol       Date:  1988-03       Impact factor: 8.317

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.